The 21st Century Cures Act: Implications for Research and Drug Development

The Forum at Harvard T.H. Chan School of Public Health

Treść dostarczona przez Harvard University and Harvard T.H. Chan School of Public Health. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Harvard University and Harvard T.H. Chan School of Public Health lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

7y ago 57:37

MP3•Źródło odcinka

Archiwalne serie ("Kanał nieaktywny" status)

When? This feed was archived on April 04, 2024 16:13 (20d ago). Last successful fetch was on April 07, 2020 19:10 (4y ago)

Why? Kanał nieaktywny status. Nasze serwery nie otrzymały odpowiedzi od kanału przez zbyt długi czas.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

The passage of the 21st Century Cures Act has drawn both applause and criticism. A sweeping bipartisan effort with multiple components, the law dramatically boosts funding for medical research, particularly in areas such as cancer and brain disease. The law also relaxes regulatory processes for pharmaceuticals and medical devices. In doing so, the law’s supporters point to the potential for faster treatments benefiting from a streamlined approval process. Critics raise concerns that safety and efficacy might be compromised, with potentially devastating consequences. And the law also has been questioned for failing to explicitly address high drug prices, a growing public issue. These debates are unfolding as the Trump administration is expected to imminently announce its choice for a new FDA commissioner, who will head an agency directly impacted by the Cures act. In this Forum, experts will explore the implications of the law for biomedicine, regulation, pharmaceuticals and patient advocacy.

This Forum event was presented jointly with STAT on February 27, 2017.

Watch the entire series at ForumHSPH.org.

51 odcinków

#Fitness #Podcasting Education #Harvard University #Harvard T.H. Chan School of Public Health #Harvard #Health and Well-Being #Public Health #Science #Research #Higher Education #News #Nutrition #Wellness #Global Health #Harvard School Of Public Health #Harvard Chan #Health Issues